21 March 2007
Daniel Christman, senior vice president of the U.S. Chamber Commerce, said Tuesday that Thailand risks losing investments by U.S. companies after the government announced its decision to break patents for certain HIV and heart drugs. "Investors look at potential destinations and judge how well intellectual property is protected when they decide to put capital in those countries,'' Christman said at a press briefing in Bangkok. "The vast majority of companies that have been surveyed by us have expressed serious concern about the future investment climate in Thailand." The chamber released results of a survey showing that 75 percent of 234 global business executives said that the recent military coup and controversial new economic policies would be factors in their final decision on investments in Thailand over the next three years.